Drug Reference
European house dust mite allergenic extract
Fact box
- Action class
- Standardized Insect Allergenic Extract
- Chemical class
- Allergens
- Habit forming
- No
Brand names
Odactra
Available as
Injectable Solution
No structured FDA label was available. Use the authoritative links below.
Current FDA labels (DailyMed)
- ODACTRA (DERMATOPHAGOIDES PTERONYSSINUS AND DERMATOPHAGOIDES FARINAE) TABLET [ALK-ABELLO A S]
- ALLERGENA FOR PETS (HOMEOPATHIC SUBLINGUAL IMMUNOTHERAPY) LIQUID [MEDITREND, INC. DBA PROGENA PROFESSIONAL FORMULATIONS]
- STANDARDIZED MITE MIX, DERMATOPHAGOIDES PTERONYSSINUS AND DERMATOPHAGOIDES FARINAE, 10000 AU PER ML INJECTION, SOLUTION STANDARDIZED MITE MIX, DERMATOPHAGOIDES PTERONYSSINUS AND DERMATOPHAGOIDES FARINAE, 30000 AU PER ML INJECTION, SOLUTION STANDARDIZED MITE, DERMATOPHAGOIDES PTERONYSSINUS, INTRADERMAL, 30 AU PER ML INJECTION, SOLUTION STANDARDIZED MITE, DERMATOPHAGOIDES PTERONYSSINUS, INTRADERMAL, 300 AU PER ML INJECTION, SOLUTION STANDARDIZED MITE, DERMATOPHAGOIDES PTERONYSSINUS, BULK, 10000 AU PER ML INJECTION, SOLUTION STANDARDIZED MITE, DERMATOPHAGOIDES PTERONYSSINUS, SCRATCH OR BULK, 30000 AU PER ML INJECTION, SOLUTION STANDARDIZED MITE, DERMATOPHAGOIDES FARINAE, INTRADERMAL, 30 AU PER ML INJECTION, SOLUTION STANDARDIZED MITE, DERMATOPHAGOIDES FARINAE, INTRADERMAL, 300 AU PER ML INJECTION, SOLUTION STANDARDIZED MITE, DERMATOPHAGOIDES FARINAE, BULK, 10000 AU PER ML INJECTION, SOLUTION STANDARDIZED MITE, DERMATOPHAGOIDES FARINAE, SCRATCH OR BULK, 30000 AU PER ML INJECTION, SOLUTION [JUBILANT HOLLISTERSTIER LLC]
- ASTHMA THERAPY (ARSENIC TRIOXIDE - HISTAMINE DIHYDROCHLORIDE - DERMATOPHAGOIDES PTERONYSSINUS - MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - STRYCHNOS NUX-VOMICA SEED - ASPIDOSPERMA QUEBRACHO-BLANCO BARK - SUPLHUR -) TABLET, ORALLY DISINTEGRATING [TRP COMPANY]
- STANDARDIZED MITE, MIXED INJECTION, SOLUTION [ALK-ABELLO, INC.]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.